Analysis reveals oral step-down therapy effective for infective endocarditis in selected patients, suggesting a need for localized strategies in South Africa.
Key Points
Oral step-down therapy shows promise in treating infective endocarditis, offering an effective alternative to intravenous therapy.
Recent studies, including the POET trial, support its safety and efficacy in clinically stable patients who clear bacteraemia.
Implementation in South Africa faces challenges due to high rates of blood culture-negative infective endocarditis and systemic healthcare constraints.
Adapting global evidence to local contexts is crucial for improving patient outcomes amid unique healthcare challenges.